Search by Journal
- HOME
- > Search by Journal
- > Journal of Japanese Society of Pharmaceutical Oncology
Journal of Japanese Society of Pharmaceutical Oncology
Volume 24, Issue / 2022


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
Comparison of Infusion Reaction Characteristics between Original Rituximab and a Rituximab Biosimilar in CD20-positive B Cell Non-Hodgkin's Lymphoma Tetsuya Ueda1, Toshihisa Nakashima1, Yayoi Fukushi1, Hironobu Hashimoto1, Koji Izutsu2, Masakazu Yamaguchi1, Tetsuya Furukawa1 Journal of Japanese Society of Pharmaceutical Oncology 24: 1-9, 2022. |
---|
![]() |
Effect of Body Surface Area on the Efficacy and Toxicity of Erlotinib in EGFR Mutation-Positive Non-Small Cell Lung Cancer Isamu Odagiri1, Kanako Takagi1, Shinsaku Washinosu2, Yukinori Hosoya2, Akihiro Uchiike2, Shinya Tsuboi2, Tatsuya Hayama2, Yasuhiro Gon3, Hiroyuki Hayashi1, Susumu Ootsuka2 Journal of Japanese Society of Pharmaceutical Oncology 24: 10-16, 2022. |
---|
![]() |
Impact of Combined Administration of Aprepitant and CHOP +- R on the Severity of Chemotherapy-induced Peripheral Neuropathy Yuki Ozawa1, Junichi Kusano1, Osamu Yoshida1, Ryusei Yamamoto1, Yuu Yabuki1, Toshihisa Nakashima2, Chien-Kang Chen3, Seiichi Hayashi1 Journal of Japanese Society of Pharmaceutical Oncology 24: 17-23, 2022. |
---|
![]() |
A Case of Dihydropyrimidine Dehydrogenase Deficiency in a Patient Who Suffered from Severe mFOLFOX6-related Adverse Events Taichi Abe1, Tatsuya Sumiya1, Tetsuya Hayashi1, Emiko Iguchi1, Mitsuyoshi Ota2, Katsuhiko Inomata1 Journal of Japanese Society of Pharmaceutical Oncology 24: 24-28, 2022. |
---|